Growing number of biologic therapies offers future opportunities for biosimilar development

EU pharmaceutical legislation reform critical to sustain… 6 October 2022 The EU plans to update its 20-year-old pharmaceutical legislation early…
European patients need improved access to biosimilar… 22 April 2021 Fifteen years after the first global approval, biosimilar medicines systemically…
New report assesses progress on biosimilar medicine policies… 29 March 2021 Biosimilar medicines are increasingly relevant to public health as emphasised by the…
IGBA: Global Roadmap for Tailored Clinical Biosimilar… 24 September 2020